Hardy Reed LLC boosted its holdings in Danaher Co. (NYSE:DHR – Free Report) by 1.3% during the third quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 5,461 shares of the conglomerate’s stock after acquiring an additional 69 shares during the period. Hardy Reed LLC’s holdings in Danaher were worth $1,518,000 at the end of the most recent quarter.
A number of other hedge funds and other institutional investors also recently bought and sold shares of the stock. Fort Pitt Capital Group LLC grew its stake in Danaher by 3.2% during the 3rd quarter. Fort Pitt Capital Group LLC now owns 238,092 shares of the conglomerate’s stock worth $66,194,000 after buying an additional 7,421 shares during the last quarter. Good Life Advisors LLC acquired a new stake in shares of Danaher in the 3rd quarter worth about $217,000. Oak Thistle LLC acquired a new stake in shares of Danaher in the 2nd quarter worth about $363,000. Harvest Portfolios Group Inc. lifted its position in Danaher by 1.2% in the 3rd quarter. Harvest Portfolios Group Inc. now owns 202,263 shares of the conglomerate’s stock valued at $56,233,000 after purchasing an additional 2,465 shares during the last quarter. Finally, Diversified Trust Co boosted its stake in Danaher by 75.4% during the 2nd quarter. Diversified Trust Co now owns 4,360 shares of the conglomerate’s stock valued at $1,090,000 after purchasing an additional 1,874 shares during the period. 79.05% of the stock is currently owned by institutional investors and hedge funds.
Analysts Set New Price Targets
DHR has been the topic of a number of recent analyst reports. Wolfe Research raised Danaher from a “peer perform” rating to an “outperform” rating and set a $285.00 price target on the stock in a report on Thursday, October 31st. UBS Group lowered their target price on Danaher from $309.00 to $305.00 and set a “buy” rating on the stock in a research report on Wednesday, October 23rd. Evercore ISI increased their price target on Danaher from $275.00 to $278.00 and gave the stock an “outperform” rating in a research note on Tuesday, October 1st. StockNews.com cut shares of Danaher from a “buy” rating to a “hold” rating in a research note on Monday, November 18th. Finally, KeyCorp upped their price objective on shares of Danaher from $290.00 to $310.00 and gave the stock an “overweight” rating in a report on Wednesday, October 23rd. Six equities research analysts have rated the stock with a hold rating and fourteen have issued a buy rating to the company. According to data from MarketBeat, the company presently has an average rating of “Moderate Buy” and an average target price of $287.16.
Danaher Stock Down 0.5 %
Shares of Danaher stock opened at $236.53 on Wednesday. The company has a quick ratio of 1.01, a current ratio of 1.37 and a debt-to-equity ratio of 0.32. Danaher Co. has a 12-month low of $215.68 and a 12-month high of $281.70. The firm has a market capitalization of $170.84 billion, a PE ratio of 45.14, a price-to-earnings-growth ratio of 4.37 and a beta of 0.85. The stock’s fifty day moving average is $256.66 and its 200-day moving average is $259.81.
Danaher (NYSE:DHR – Get Free Report) last announced its earnings results on Tuesday, October 22nd. The conglomerate reported $1.71 EPS for the quarter, topping the consensus estimate of $1.57 by $0.14. The company had revenue of $5.80 billion during the quarter, compared to analysts’ expectations of $5.59 billion. Danaher had a net margin of 16.39% and a return on equity of 10.62%. The business’s revenue for the quarter was up 3.1% on a year-over-year basis. During the same period last year, the company posted $2.02 earnings per share. Equities analysts anticipate that Danaher Co. will post 7.5 earnings per share for the current year.
Danaher Dividend Announcement
The firm also recently announced a quarterly dividend, which was paid on Friday, October 25th. Stockholders of record on Friday, September 27th were given a $0.27 dividend. The ex-dividend date was Friday, September 27th. This represents a $1.08 annualized dividend and a dividend yield of 0.46%. Danaher’s dividend payout ratio (DPR) is presently 20.61%.
About Danaher
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.
Read More
- Five stocks we like better than Danaher
- The Top 3 Healthcare Dividend Stocks to Buy and Hold
- 2 Essential Data Center Solutions Providers Riding the AI Boom
- With Risk Tolerance, One Size Does Not Fit All
- Holiday Cheer or Market Fear: Navigating the Year-End Rally
- Why Invest in High-Yield Dividend Stocks?
- Gold vs. Silver: Profit Opportunities in the Widening Spread
Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Co. (NYSE:DHR – Free Report).
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.